Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis
2024 · Molecular Therapy — Methods & Clinical Development · 4 citations
https://doi.org/10.1016/j.omtm.2024.101318